MMP-2 concentrations in stroke according to etiology: Adjusting for enzyme degradation in stored deep-frozen serum and other methodological pitfalls

Journal of Clinical Neuroscience

Volumn 19, Issue 11, 2012, Pages 1564-1567

  Kreisel, Stefan H ^a,b   Stroick, Mark ^a   Reuter, Björn ^a   Senn, Eva ^a,c   Hennerici, Michael G ^a   Fatar, Marc ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c St Vincentius Kliniken Karlsruhe   (Germany)

Author keywords

Cryopreservation; Linear models; Matrix metalloproteinase 2; Stroke

Indexed keywords

GELATINASE A;

ADULT; ARTICLE; BLOOD ANALYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STORAGE;

AGED; BLOOD PRESERVATION; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HUMANS; LINEAR MODELS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; STROKE;

EID: 84867097216     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2011.10.026     Document Type: Article

References (24)

1. L.A. Cunningham, M. Wetzel, and G.A. Rosenberg Multiple roles for MMPs and TIMPs in cerebral ischemia Glia 50 2005 329 339
2. V.W. Yong Metalloproteinases: mediators of pathology and regeneration in the CNS Nat Rev Neurosci 6 2005 931 944
3. B.Q. Zhao, E. Tejima, and E.H. Lo Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke Stroke 38 2007 748 752
4. M. Fatar, M. Stroick, and M. Steffens Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes Cerebrovasc Dis 26 2008 113 119
5. D. Rouy, I. Ernens, and C. Jeanty Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation Anal Biochem 338 2005 294 298
6. J.E. Noble, L. Wang, and E. Cerasoli An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA Clin Chem Lab Med 46 2008 1033 1045
7. B. Reuter, P. Bugert, and M. Stroick TIMP-2 gene polymorphism is associated with intracerebral hemorrhage Cerebrovasc Dis 28 2009 558 563
8. A. Skrondal, and S. Rabe-Hesketh Generalized latent variable modelling. Multilevel, longitudinal, and structural equation models 2004 Chapman & Hall Boca Raton, USA
9. I. Vukasovic, A. Tesija-Kuna, and E. Topic Matrix metalloproteinases and their inhibitors in different acute stroke subtypes Clin Chem Lab Med 44 2006 428 434
10. J. Montaner, J. Alvarez-Sabin, and C. Molina Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment Stroke 32 2001 1759 1766
11. V. Lucivero, M. Prontera, and D.M. Mezzapesa Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke Neurol Sci 28 2007 165 170
12. J. Montaner, J. Alvarez-Sabin, and C.A. Molina Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke Stroke 32 2001 2762 2767
13. R.E. Gislefoss, T.K. Grimsrud, and L. Morkrid Stability of selected serum proteins after long-term storage in the Janus Serum Bank Clin Chem Lab Med 47 2009 596 603
14. R.W. Evans, S.S. Sankey, and B.A. Hauth Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay Lipids 31 1996 1197 1203
15. G. Bolelli, P. Muti, and A. Micheli Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma Cancer Epidemiol Biomarkers Prev 4 1995 509 513
16. B. Halfon, H. Khiri, and V. Gerolami Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA J Hepatol 25 1996 307 311
17. K. Jung, C. Laube, and M. Lein Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 2 in blood Clin. Chem 44 1998 1060 1062
18. Q.X. Sang, H.E. Birkedal-Hansen, and H.E. Van Wart Proteolytic and non-proteolytic activation of human neutrophil progelatinase B Biochim Biophys Acta 1251 1995 99 108
19. N. Aziz, P. Nishanian, and R. Mitsuyasu Variables that affect assays for plasma cytokines and soluble activation markers Clin Diagn Lab Immunol 6 1999 89 95
20. C.D. Souza-Tarla, J.A. Uzuelli, and A.A. Machado Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities Clin Biochem 38 2005 410 414
21. M. Castellanos, T. Sobrino, and M. Millan Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study Stroke 38 2007 1855 1859
22. J. Montaner, C.A. Molina, and J. Monasterio Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 107 2003 598 603
23. S. Zucker, and J. Cao Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls Clin Cancer Res 11 2005 5069 5070
24. A.G. Rundle, P. Vineis, and H. Ahsan Design options for molecular epidemiology research within cohort studies Cancer Epidemiol Biomarkers Prev 14 2005 1899 1907